Ion Beam Applications, SA

Declaration of Voting Results & Voting Rights Announcements • Apr 27, 2012

Press release |

Regulatory information

IBA – DATA CONCERNING TRANSPARENCY

For immediate publication – 27 April 2012

Louvain-la-Neuve, Belgium, 27 April 2012 - IBA (Ion Beam Applications SA) communicates today the basic and additional data as per Article 15 §1 al.1 of the Transparency Law, following its capital increase dated 27 April 2012.

Data concerning transparency Heading II of the law of May 2, 2007 and the Royal Decree of February 14, 2008

Communication of the basic data as per Article 15 §1 al.1 of the Law

	Total capital: Total number of securities conferring the voting right: 12 630 938 with VVPR strips)	EUR 38 408 427.14 27 365 528 (of which
	Total number of voting rights (= the denominator):	27 365 528
	Total number of securities conferring the voting right, by category:	N/A
	Total number of voting rights, by category:	N/A
Communication of the additional data as per Article 15 §1 al.2 of the Law
	Total number of convertible bonds conferring the voting right: Total number of rights, materialized or not by certificates, giving the	0
	right to subscribe to newly issued securities conferring the voting right
	(e.g. warrants): Total number of voting rights which would result from the exercise of	2 597 268
	these conversion or subscription rights:	2 597 268
	Total number of shares without voting right:	0

Statutory thresholds as per Article 18 of the Law

The applicable thresholds as follows: three percent, five percent, ten percent, fifteen percent and so on by brackets of five percent.

Contact person IBA Xavier Defourt, Chief Legal Officer +32 10 48 77 82 xavier.defourt@iba-group.com.

ABOUT IBA

Founded in 1986 in Louvain-la-Neuve, Belgium, IBA is primarily active in the medical industry. It develops and markets state-of-the-art equipment and radiopharmaceuticals for cancer diagnosis and treatment. In addition, it uses the scientific expertise thus gained to provide electron accelerators for industrial sterilization and ionization. Listed on the pan-European stock exchange Euronext, IBA is included in the BEL Mid Index (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB).

Website: http://www.iba-worldwide.com

Press release | 27 April 2012 1 | 1